AstraZeneca (AZN)
Discover more about AstraZeneca (AZN), including the latest news, insights and features. Kiplinger has you covered for AstraZeneca (AZN) updates.
Latest
-
9 Big Pharmaceutical Stocks Sporting Stellar Yields
healthcare stocks Large-cap pharmaceutical stocks offer investors stable, substantial dividends, regardless of market conditions. Here are nine that stand out.
By Jeff Reeves • Published
-
7 Impressive International Stocks Set to Fly
stocks With the S&P 500 trading near record highs, U.S. stocks are looking pricey these days. This list of international stocks could provide a better value for buy-and-hold investors.
By Deborah Yao • Published
-
Stock Market Today 3/23/21: Stocks Fall on Anniversary of Bear Market Bottom
Stock Market Today Rising short-term COVID concerns, including lockdowns in Europe and a trial-vaccine stumble, pulled down stocks across the board Tuesday.
By Kyle Woodley • Published
-
Stock Market Today 12/30/20: Dow Nicks New High in 2020's Penultimate Session
Stock Market Today A Wednesday session light on trading volume and news alike ended in slight gains, with the Dow setting another fresh closing high.
By Kyle Woodley • Published
-
Stock Market Today 12/14/20: Stocks Step Back as COVID Battle Escalates
Stock Market Today Energy from the first COVID-vaccine approval in the U.S. quickly died out Monday as growing closure threats mounted.
By Kyle Woodley • Published
-
Stock Market Today 11/27/20: Nasdaq Notches Another High as COVID's Spread Worsens
stocks An error in AstraZeneca's COVID-19 vaccine trial and persistent coronavirus troubles in the U.S. led investors to chase the old COVID trade Friday.
By Kyle Woodley • Published
-
Stock Market Today 11/23/20: Stocks Start Another Week With a Vaccine Bump
stocks Equities rallied Monday after data showed high efficacy for an AstraZeneca (AZN) vaccine that could be more easily distributed than its peers.
By Kyle Woodley • Published
-
Stock Market Today 10/13/20: Another Vaccine-Trial Stumble Clips Wall Street's Optimism
stocks Johnson & Johnson (JNJ) paused a vaccine study, and Eli Lilly (LLY) was forced to do the same on a treatment trial, hampering stocks Tuesday.
By Kyle Woodley • Published
-
Stock Market Today 9/9/20: Nasdaq Comes to Life in Raucous Rebound
Markets The Nasdaq reversed course from its quickest-ever correction with sizable gains Wednesday, led by the usual suspects.
By Kyle Woodley • Published
-